Evaluation of toceranib for treatment of apocrine gland anal sac adenocarcinoma in dogs

BACKGROUND: There is no widely accepted standard medical treatment for apocrine gland anal sac adenocarcinoma (AGASACA) in dogs. Targeted agents such as toceranib may be effective in treatment of AGASACA, but the number of clinical reports investigating its efficacy is limited. HYPOTHESIS/AIM: To ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Heaton, Caitlin M., Fernandes, Arthur F. A., Jark, Paulo C., Pan, Xuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096647/
https://www.ncbi.nlm.nih.gov/pubmed/31977135
http://dx.doi.org/10.1111/jvim.15706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096647/
https://www.ncbi.nlm.nih.gov/pubmed/31977135
http://dx.doi.org/10.1111/jvim.15706

Ejemplares similares